PLRZ — Polyrizon Ltd.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for PLRZ in the TickerWise workspace.

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: IL
• Exchange: NASDAQ
• Employees: 2
• Website: https://www.polyrizon-biotech.com

Latest SEC filings for PLRZ

• 2026-10-07S-8
• 2026-10-02EFFECT
• 2026-09-28F-1/A
• 2026-09-286-K
• 2026-09-18F-1
• 2026-09-10D
• 2026-09-046-K
• 2026-09-04424B5
• 2026-09-046-K
• 2026-08-206-K

Latest PLRZ news

• 2026-10-05Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform Read article
• 2026-09-28Polyrizon Ltd. GAAP EPS of -$0.79 Read article

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.